12 Health Care Stocks Moving In Monday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's after-market session, health care stocks saw significant movements. Vicarious Surgical (RBOT) led the gainers with a 24.9% increase following their Q4 earnings report. Ekso Bionics Holdings (EKSO) and Jaguar Health (JAGX) also posted strong gains after their Q4 earnings. On the losing side, Cara Therapeutics (CARA) dropped 15% after its Q4 earnings, with Moleculin Biotech (MBRX) and Tandem Diabetes Care (TNDM) also experiencing declines.
March 04, 2024 | 9:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cara Therapeutics' shares fell 15% to $0.85, with a market cap of $46.3 million after their Q4 earnings report.
The decline in CARA's stock price is a direct consequence of the market's negative reaction to their Q4 earnings report, indicating concerns over their financial health.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Ekso Bionics Holdings' stock rose 21.42% to $2.55, with a market cap of $45.4 million following their Q4 earnings.
The increase in EKSO's stock price can be linked to the positive investor response to their Q4 earnings report, suggesting strong financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Vicarious Surgical's stock surged 24.9% to $0.45 after their Q4 earnings report, with a market cap of $78.6 million.
The significant surge in RBOT's stock price is directly attributed to the positive reception of their Q4 earnings report, indicating strong investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90